Literature DB >> 20360944

Pigment epithelium-derived factor stimulates tumor macrophage recruitment and is downregulated by the prostate tumor microenvironment.

Sofia Halin1, Stina Häggström Rudolfsson, Jennifer A Doll, Susan E Crawford, Pernilla Wikström, Anders Bergh.   

Abstract

Pigment epithelium-derived factor (PEDF) is a potent inhibitor of angiogenesis but whether it has additional effects on the tumor microenvironment is largely unexplored. We show that overexpression of PEDF in orthotopic MatLyLu rat prostate tumors increased tumor macrophage recruitment. The fraction of macrophages expressing inducible nitric oxide synthase, a marker of cytotoxic M1 macrophages, was increased, suggesting that PEDF could enhance antitumor immunity. In addition, PEDF overexpression reduced vascular growth both in the tumor and in the surrounding normal tissue, slowed tumor growth, and decreased lymph node metastasis. Contrary, extratumoral lymphangiogenesis was increased. PEDF expression is, for reasons unknown, often decreased or lost during prostate tumor progression. When AT-1 rat prostate tumor cells, expressing high levels of PEDF messenger RNA (mRNA) and protein, were injected into the prostate, PEDF is markedly downregulated, suggesting that factors in the microenvironment suppressed its expression. One such factor could be macrophage-derived tumor necrosis factor alpha (TNFalpha). A fraction of the accumulating macrophages expressed TNFalpha, and TNFalpha treatment downregulated the expression of PEDF protein and mRNA in prostate AT-1 tumor cells in vitro and in the rat ventral prostate in vivo. PEDF apparently has multiple effects in prostate tumors: it suppresses angiogenesis and metastasis, but it also causes macrophage accumulation. Accumulating macrophages may inhibit tumor growth, but they may also suppress PEDF and enhance lymph angiogenesis and, in this way, eventually enhance tumor growth.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20360944      PMCID: PMC2847741          DOI: 10.1593/neo.92046

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  60 in total

1.  Pigment epithelial growth factor suppresses inflammation by modulating macrophage activation.

Authors:  Parisa Zamiri; Sharmila Masli; J Wayne Streilein; Andrew W Taylor
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-09       Impact factor: 4.799

2.  Pigment epithelium-derived factor: a potent inhibitor of angiogenesis.

Authors:  D W Dawson; O V Volpert; P Gillis; S E Crawford; H Xu; W Benedict; N P Bouck
Journal:  Science       Date:  1999-07-09       Impact factor: 47.728

3.  Reduced infiltration of tumor-associated macrophages in human prostate cancer: association with cancer progression.

Authors:  S Shimura; G Yang; S Ebara; T M Wheeler; A Frolov; T C Thompson
Journal:  Cancer Res       Date:  2000-10-15       Impact factor: 12.701

4.  Adeno-associated virus vector-mediated delivery of pigment epithelium-derived factor restricts neuroblastoma angiogenesis and growth.

Authors:  Christian J Streck; Youbin Zhang; Junfang Zhou; Catherine Ng; Amit C Nathwani; Andrew M Davidoff
Journal:  J Pediatr Surg       Date:  2005-01       Impact factor: 2.545

5.  Loss of pigment epithelium derived factor expression in glioma progression.

Authors:  M Guan; H-F Yam; B Su; K-P Chan; C-P Pang; W-W Liu; W-Z Zhang; Y Lu
Journal:  J Clin Pathol       Date:  2003-04       Impact factor: 3.411

6.  Expression of pigment epithelial derived factor is reduced in non-small cell lung cancer and is linked to clinical outcome.

Authors:  Lijian Zhang; Jinfeng Chen; Yang Ke; Robert E Mansel; Wen G Jiang
Journal:  Int J Mol Med       Date:  2006-05       Impact factor: 4.101

7.  Pigment epithelium-derived factor overexpression inhibits orthotopic osteosarcoma growth, angiogenesis and metastasis.

Authors:  E T H Ek; C R Dass; K G Contreras; P F M Choong
Journal:  Cancer Gene Ther       Date:  2007-05-04       Impact factor: 5.987

8.  Maspin reduces prostate cancer metastasis to bone.

Authors:  Devon C Hall; Teresa L Johnson-Pais; Barry Grubbs; Rosie Bernal; Robin J Leach; Susan S Padalecki
Journal:  Urol Oncol       Date:  2008-01-15       Impact factor: 3.498

9.  Expression of pigment epithelium-derived factor decreases liver metastasis and correlates with favorable prognosis for patients with ductal pancreatic adenocarcinoma.

Authors:  Hirofumi Uehara; Masaki Miyamoto; Kentaro Kato; Yuma Ebihara; Hiroyuki Kaneko; Hiroyuki Hashimoto; Yoshihiro Murakami; Ryunosuke Hase; Ryo Takahashi; Seiji Mega; Toshiaki Shichinohe; You Kawarada; Tomoo Itoh; Shunichi Okushiba; Satoshi Kondo; Hiroyuki Katoh
Journal:  Cancer Res       Date:  2004-05-15       Impact factor: 12.701

10.  Decreased pigment epithelium-derived factor expression in human breast cancer progression.

Authors:  Jun Cai; Christian Parr; Gareth Watkins; Wen G Jiang; Mike Boulton
Journal:  Clin Cancer Res       Date:  2006-06-01       Impact factor: 12.531

View more
  27 in total

1.  The interconnectedness of cancer cell signaling.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2011-12       Impact factor: 5.715

Review 2.  Lipid Metabolism in Tumor-Associated Fibroblasts.

Authors:  Hongzhong Li; Jingyuan Wan
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  PEDF regulates plasticity of a novel lipid-MTOC axis in prostate cancer-associated fibroblasts.

Authors:  Francesca Nardi; Philip Fitchev; Omar E Franco; Jelena Ivanisevic; Adrian Scheibler; Simon W Hayward; Charles B Brendler; Michael A Welte; Susan E Crawford
Journal:  J Cell Sci       Date:  2018-07-11       Impact factor: 5.285

4.  Melanoma Cells Block PEDF Production in Fibroblasts to Induce the Tumor-Promoting Phenotype of Cancer-Associated Fibroblasts.

Authors:  Nkechiyere G Nwani; Maria L Deguiz; Benilde Jimenez; Elena Vinokour; Oleksii Dubrovskyi; Andrey Ugolkov; Andrew P Mazar; Olga V Volpert
Journal:  Cancer Res       Date:  2016-02-26       Impact factor: 12.701

5.  Dinosaurs and ancient civilizations: reflections on the treatment of cancer.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2010-12       Impact factor: 5.715

6.  Prostate cancer increases hyaluronan in surrounding nonmalignant stroma, and this response is associated with tumor growth and an unfavorable outcome.

Authors:  Andreas Josefsson; Hani Adamo; Peter Hammarsten; Torvald Granfors; Pär Stattin; Lars Egevad; Anna Engström Laurent; Pernilla Wikström; Anders Bergh
Journal:  Am J Pathol       Date:  2011-08-18       Impact factor: 4.307

7.  Positive correlation between PEDF expression levels and macrophage density in the human prostate.

Authors:  Thomas Nelius; Christina Samathanam; Dalia Martinez-Marin; Natalie Gaines; Jessica Stevens; Johnny Hickson; Werner de Riese; Stéphanie Filleur
Journal:  Prostate       Date:  2012-10-04       Impact factor: 4.104

8.  KRAS mutation and epithelial-macrophage interplay in pancreatic neoplastic transformation.

Authors:  Faraz Bishehsari; Lijuan Zhang; Usman Barlass; Nailliw Z Preite; Sanja Turturro; Matthew S Najor; Brandon B Shetuni; Janet P Zayas; Mahboobeh Mahdavinia; Abde M Abukhdeir; Ali Keshavarzian
Journal:  Int J Cancer       Date:  2018-08-09       Impact factor: 7.396

9.  Thrombospondin-1 and pigment epithelium-derived factor enhance responsiveness of KM12 colon tumor to metronomic cyclophosphamide but have disparate effects on tumor metastasis.

Authors:  Li Jia; David J Waxman
Journal:  Cancer Lett       Date:  2012-12-08       Impact factor: 8.679

Review 10.  The effects of PEDF on cancer biology: mechanisms of action and therapeutic potential.

Authors:  S Patricia Becerra; Vicente Notario
Journal:  Nat Rev Cancer       Date:  2013-03-14       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.